
Disease Unit for Myocarditis & Arrhythmogenic Cardiomyopathies at @SanRaffaeleMI @SRArrhythmology
Joined September 2022
- Tweets22
- Following133
- Followers112
- Likes50
We are proud to announce that our research project GEAM: yield of GEnetic testing in Arrhythmic Myocarditis, led by Dr. Giovanni Peretto, was funded with the Early Career Award by Fondazione Regionale per la Ricerca Biomedica (FRRB) and Regione Lombardia. hsr.it/news/2024/luglio/band…
We propose a research project aimed at: 1) defining the prevalence of CGVs with arrhythmic myocarditis, with a special focus on gender differences; 2) describing the prognostic value of CGVs; (...)
We explored pentraxin 3 (PTX3), an acute phase protein, as a potential biomarker in plasma and cardiac biopsies of patients with myocarditis.
#myocarditis
link.springer.com/article/10…
💡Cardiac tissue analysis revealed PTX3 expression in all patients, with viral myocarditis exhibiting higher signal intensity than autoimmune myocarditis, and with a predominant localization in cardiomyocytes.
San Raffaele Myocarditis & Cardiomyopathies retweeted
Amazing appointment to share and spread the knowledge about #Fabry disease 💫
Old friends, beautiful city #naples, excellent organization!
#FabryAcademyforYoungDoctors 🌟
#CardioEd #Cardiotwitter #MedEd
@CriChimenti @glimongelli @mauripieroni72 @OssMalattieRare
San Raffaele Myocarditis & Cardiomyopathies retweeted
Detecting and targeting inflammation in genetic cardiomyopathies: Are we there yet?
Read the editorial by @spinneymd & @DLMann_MD on the new #JACCBTS study by @GiovanniPeretto & colleagues: bit.ly/47mwHyL
#HeartFailure #CardioRheum #CardioTwitter
San Raffaele Myocarditis & Cardiomyopathies retweeted
A very important study. Inflammation in the heart, in the context of LV dysfunction, cannot be a good thing. More data is needed, but this study gives us some light #cardiacimmunology
Use of multimodal imaging in genetic cardiomyopathies may allow for the identification of myocardial inflammation potentially responsive to immunomodulatory therapy.
Read the new #JACCBTS study by @GiovanniPeretto et al here: bit.ly/3Y7BTSI
#HeartFailure #CardioRheum
San Raffaele Myocarditis & Cardiomyopathies retweeted
Use of multimodal imaging in genetic cardiomyopathies may allow for the identification of myocardial inflammation potentially responsive to immunomodulatory therapy.
Read the new #JACCBTS study by @GiovanniPeretto et al here: bit.ly/3Y7BTSI
#HeartFailure #CardioRheum
San Raffaele Myocarditis & Cardiomyopathies retweeted
Dr. @GiovanniPeretto, et al investigate the prognostic value of genetic testing and histology in a cohort of undefined left ventricular arrhythmogenic #cardiomyopathy patients ➡️ bit.ly/3Y4tyz9
#JACCCEP #EPeeps #MACE #CardioTwitter
Our new pilot report of 25 patients with genetic cardiomyopathy and biopsy-proven myocardial inflammation. M-Infl was characterized by multimodal imaging, including CMR and PET, and treated with immunomodulatory therapy for the first time in NGS+ patients. doi.org/10.1016/j.jacbts.202…
Functional characterisation of the rare SCN5A p.E1225K variant, segregating in a Brugada syndrome familial case, which caused an impairment of the mutated Nav1.5 in human cardiomyocytes from pluripotent stem cells.
doi.org/10.3390/ijms24119548
From bedside to the bench, the role of myocardial inflammation (M-Infl) is emerging in the pathophysiology, phenotype, and treatment of traditionally genetic cardiomyopathies (DCM/ACM). Check our "hot off the press" review!
doi.org/10.3390/biom13040646
San Raffaele Myocarditis & Cardiomyopathies retweeted
Do not miss #ESCWebinar Management of ventricular arrhythmias in myocarditis esc365.escardio.org/event/89… #GiovanniPeretto and #ChristiandeChillou @SRArrhythmology
San Raffaele Myocarditis & Cardiomyopathies retweeted
Presentation with malignant VA or biopsy-proven active inflammation (AM) associates with MACE in patients with undefined left ventricular arrhythmogenic cardiomyopathy (ULVACM).
jacc.org/doi/10.1016/j.jacep…
@JACCJournals @SRMyocarditis @GiovanniPeretto

















